{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:04:39Z","timestamp":1777471479796,"version":"3.51.4"},"reference-count":66,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,2,4]],"date-time":"2008-02-04T00:00:00Z","timestamp":1202083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction Biology"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Acamprosate and naltrexone are widely used in the treatment of alcoholism. However, numerous studies in rodents have shown differential effects of these compounds on alcohol consumption and\/or relapse\u2010like behavior following acute versus repeated administration. In order to determine if these differential behavioral effects could be attributable to changes in extracellular levels of these compounds, we used <jats:italic>in vivo<\/jats:italic> microdialysis to monitor extracellular levels of acamprosate and naltrexone in the rat medial prefrontal cortex following acute and repeated intraperitoneal administration. For acute treatment, animals received a single administration of acamprosate (100 or 300\u2003mg\/kg) or naltrexone (1 or 3\u2003mg\/kg). For repeated treatment, animals received once daily treatment with saline, acamprosate (300\u2003mg\/kg) or naltrexone (3\u2003mg\/kg) for 10 days before a subsequent challenge with the compound according to their respective pretreatment group. Dialysate levels of acamprosate and naltrexone were analyzed by liquid chromatography\u2013tandem mass spectrometry and high performance liquid chromatography, respectively. Following acute administration, peak dialysate concentrations of each compound were dose\u2010dependent, observed within 1 hour of administration, and were found to be in the low micromolar range for acamprosate and in the low to mid\u2010nanomolar range for naltrexone. Pretreatment with acamprosate, but not naltrexone, for 10 days resulted in higher dialysate concentrations of the compound relative to saline\u2010pretreated controls. Thus, repeated administration of acamprosate, but not naltrexone, results in augmented extracellular levels of the compound in the brain relative to saline\u2010pretreated controls, which may explain the need for repeated administration of acamprosate in order to observe effects on alcohol consumption and\/or relapse.<\/jats:p>","DOI":"10.1111\/j.1369-1600.2008.00097.x","type":"journal-article","created":{"date-parts":[[2008,2,4]],"date-time":"2008-02-04T11:48:11Z","timestamp":1202125691000},"page":"70-79","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["PRECLINICAL STUDY: A microdialysis study of extracellular levels of acamprosate and naltrexone in the rat brain following acute and repeated administration"],"prefix":"10.1111","volume":"13","author":[{"given":"Costanza","family":"Burattini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Mcgeehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"William C.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin T.","family":"Gass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Kinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia H.","family":"Janak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Foster","family":"Olive","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,2,4]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002100000285"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(80)90257-X"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1998.tb03636.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00245-9"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1998.tb03661.x"},{"key":"e_1_2_6_7_1","first-page":"139A","article-title":"A microdialysis study of extracellular levels of acamprosate and naltrexone in the rat brain following acute and repeated administration","volume":"31","author":"Burattini C","year":"2007","journal-title":"Alcohol Clin Exp Rse"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2003.11.001"},{"key":"e_1_2_6_9_1","first-page":"273","article-title":"Review of naltrexone, a long\u2010acting opiate antagonist","volume":"3","author":"Crabtree BL","year":"1984","journal-title":"Clin Pharmacol"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2001.tb02220.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(88)90125-6"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600730510"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200519060-00004"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-80193-8_3"},{"key":"e_1_2_6_15_1","first-page":"548","article-title":"Rat pharmacokinetic profile of acamprosate in plasma, brain and CSF","volume":"30","author":"Durbin PH","year":"1995","journal-title":"Alcohol Alcohol"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-199508000-00039"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2006.00004.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)03026-2"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1996.tb01097.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1997.tb04473.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.alcalc.a045093"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2006.02.001"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(97)00130-9"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/15265160601063969"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1997.tb03850.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1976.tb27938.x"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.8.1403"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2004.01189.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0741-8329(87)90005-X"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2003.tb00492.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e318156c26f"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1996.tb01667.x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.903500307"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(88)90093-8"},{"key":"e_1_2_6_35_1","first-page":"42","article-title":"Treatment of alcohol\u2010dependent outpatients with acamprosate: a clinical review","volume":"62","author":"Mason BJ","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(02)00368-8"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000479"},{"key":"e_1_2_6_38_1","first-page":"276","article-title":"Disposition of (15,16\u20103H)naltrexone in the central nervous system of the rat","volume":"4","author":"Misra AL","year":"1976","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/36.5.357"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0741-8329(86)90058-3"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1998.tb03871.x"},{"key":"e_1_2_6_42_1","volume-title":"Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research","author":"National Research Council","year":"2003"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(01)02361-7"},{"key":"e_1_2_6_44_1","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos G","year":"2005"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00195-3"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00008-9"},{"key":"e_1_2_6_47_1","first-page":"330","article-title":"Pharmacological characterization of the cloned \u03ba\u2010, \u03b4\u2010, and \u00b5\u2010opioid receptors","volume":"45","author":"Raynor K","year":"1994","journal-title":"Mol Pharmacol"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1996.tb01130.x"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0751685.x"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2005.11.001"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.000246223.94119.cd"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(89)90655-9"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1515\/IJAMH.2006.18.1.139"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199835050-00001"},{"key":"e_1_2_6_55_1","first-page":"111","article-title":"Impairment of blood\u2010brain barrier (BBB) in rat by immobilization stress: role of serotonin (5\u2010HT)","volume":"25","author":"Sharma HS","year":"1981","journal-title":"Indian J Physiol Pharmacol"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0361-9230(97)00335-3"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.7.17.2341"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00174-4"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(97)00131-6"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(00)00137-3"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1998.tb05932.x"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(97)00659-3"},{"key":"e_1_2_6_63_1","first-page":"147","article-title":"The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics","volume":"28","author":"Verebey K","year":"1981","journal-title":"NIDA Res Monogr"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1976203315"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(85)90322-4"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90682-8"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.513"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1369-1600.2008.00097.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1369-1600.2008.00097.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:04:07Z","timestamp":1697429047000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1369-1600.2008.00097.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,4]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1111\/j.1369-1600.2008.00097.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1369-1600.2008.00097.x","archive":["Portico"],"relation":{},"ISSN":["1355-6215","1369-1600"],"issn-type":[{"value":"1355-6215","type":"print"},{"value":"1369-1600","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,4]]},"assertion":[{"value":"2008-02-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}